High dose busulfan, cyclophosphamide and etoposide as a conditioning regimen for autologous progenitor cell transplantation in patients with multiple myeloma.

被引：0
|
作者：
Cogle, CR [1 ]
Moreb, JS [1 ]
Belanger, GL [1 ]
Leather, HL [1 ]
Boyette, RM [1 ]
Finiewicz, K [1 ]
Khan, SA [1 ]
Reddy, VS [1 ]
Wingard, JR [1 ]
机构：
[1] Univ Florida, Shands Canc Ctr, Gainesville, FL USA
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5343
引用
收藏
页码：368B / 368B
页数：1
相关论文
共 50 条
  • [1] Busulfan, cyclophosphamide, and etoposide as conditioning for autologous stem cell transplantation in multiple myeloma
    Cogle, CR
    Moreb, JS
    Leather, HL
    Finiewicz, KJ
    Khan, SA
    Reddy, VS
    Wingard, JR
    AMERICAN JOURNAL OF HEMATOLOGY, 2003, 73 (03) : 169 - 175
  • [2] Busulfan,cyclophosphamide and etoposide as conditioning for autologous stem cell transplantation in multiple myeloma
    张春阳
    China Medical Abstracts (Internal Medicine), 2013, 30 (02) : 116 - 117
  • [3] High dose melphalan (HDM) is superior to cyclophosphamide plus etoposide and busulfan (CVB) as the conditioning regimen in autologous stem cell transplantation for multiple myeloma
    谷景立
    China Medical Abstracts (Internal Medicine), 2019, 36 (04) : 230 - 231
  • [4] Intravenous busulfan with thiotepa and cyclophosphamide (TBC) as a conditioning regimen for autologous progenitor cell transplantation (PCT) in patients with multiple myeloma (MM).
    Anagnostopoulos, A
    Aleman, A
    Weber, D
    Andersson, B
    Braunschweig, I
    Claxton, D
    Donato, M
    Khouri, I
    Anderlini, P
    Korbling, M
    Gajewski, J
    Alexanian, R
    Champlin, R
    Giralt, S
    BLOOD, 1999, 94 (10) : 335A - 335A
  • [5] Application of the Conditioning Regimen with Busulfan and Cyclophosphamide in Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
    Xu, Yun
    Yao, Ying
    Yao, Weiqin
    Jin, Song
    Yan, Lingzhi
    Shang, Jingjing
    Fu, Chengcheng
    Wu, Depei
    BLOOD, 2017, 130
  • [6] APPLICATION OF CONDITIONING REGIMEN WITH BUSULFAN AND CYCLOPHOSPHAMIDE IN AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA
    Xu, Y.
    Fu, C.
    Yao, Y.
    Yao, W.
    Jin, S.
    Yan, L.
    Shang, J.
    Zhu, X.
    Sun, A.
    Wu, D.
    HAEMATOLOGICA, 2017, 102 : 787 - 787
  • [7] Progenitor cell transplantation (PCT) in children with a conditioning regimen of busulfan, cyclophosphamide and etoposide.
    Mustafa, MM
    El Solh, H
    Ayas, M
    Al-Mahr, M
    Al-Jefri
    BLOOD, 1998, 92 (10) : 353B - 353B
  • [8] Individualized high dose busulfan in patients undergoing autologous stem cell transplantation for multiple myeloma.
    Clopés, A
    Sureda, A
    Brunet, S
    Altés, A
    Martino, R
    Paladio, N
    Queraltó, JM
    Mangues, MA
    Sierra, J
    BLOOD, 2001, 98 (11) : 201A - 201A
  • [9] BUSULFAN PLUS CYCLOPHOSPHAMIDE AND ETOPOSIDE VERSUS HIGH-DOSE MELPHALAN AS CONDITIONING IN AUTOLOGOUS STEM CELL TRANSPLANTATION FOR NEWLY DIAGNOSED MULTIPLE MYELOMA
    Park, Seonyang
    Lee, Youngjoon
    Lim, Sungnam
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 484 - 484
  • [10] Busulfan and thiotepa as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma
    Song, Ga-Young
    Jung, Sung-Hoon
    Kim, Mihee
    Ahn, Seo-Yeon
    Ahn, Jae-Sook
    Yang, Deok-Hwan
    Kim, Hyeong-Joon
    Kim, Jin Seok
    Eom, Hyeon-Seok
    Moon, Joon Ho
    Yhim, Ho-Young
    Kim, Kihyun
    Min, Chang-Ki
    Lee, Je-Jung
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S157 - S158
12345